LONDON MARKET MIDDAY: Stocks fall as Evergrande silence sparks fear Read More
LONDON MARKET OPEN: JD Sports falls after Nike cuts revenue forecast Read More
AstraZeneca's Lynparza meets primary endpoint in prostate cancer trial Read More
TOP NEWS: Oxford BioMedica sales double; Serum Institute buys stake Read More
AstraZeneca to invest USD360 million in Irish manufacturing facility Read More
LONDON MARKET MIDDAY: Stocks sink on Evergrande contagion fears Read More
UPDATE: AstraZeneca notes positive test results for new cancer drugs Read More
UPDATE: AstraZeneca reports positive test results for new cancer drugs Read More
LONDON MARKET OPEN: FTSE 100 drops to two-month low; Prudential sinks Read More
TOP NEWS: AstraZeneca says Enhertu breast cancer drug improves survival Read More
AstraZeneca sees positive result for Imfinzi in lung cancer patients Read More
UPDATE: Booster Covid jab to be offered in UK to people aged over 50 Read More
Work-from-home guidance and face masks can be back in winter in UK Read More
UK cancels Covid vaccine contract with Franco-Austrian firm Valneva Read More
UK shelves vaccine passport plan as PM to set out winter virus plan Read More
IN BRIEF: Cizzle eyes royalties after encouraging Covid drug results Read More
LONDON BROKER RATINGS: Credit Suisse raises boohoo; Peel cuts Genus Read More
AstraZeneca's asthma treatment trials meet primary endpoints Read More
Hutchmed, Astra launch drug combination trial to treat lung cancer Read More
AstraZeneca chief calls for UK to hold off booster jabs for now Read More
